Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus

Mitra Niafar ¹, Leili Pourafkari ², Kavus Shahsavarinia ¹, Nushin Milanchian ¹, Farhad Niafar ¹, Nader D. Nader ² *

Cited by CrossRef: 1

1- Siamashvili M, Davis S. Late phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy. 2021;22(2):241 [Crossref]

Platinum Open Access

This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central. All related costs for processing of the manuscripts are sponsored by Tabriz University of Medical Sciences.

Indexing Info